Active Pharmaceutical Ingredient

Umirolimus (Biolimus) API Manufacturer & Supplier in India

Also known as: Biolimus A9; TRM-986

CAS: 851536-75-9mTOR Inhibitor APIBiolimus A9IP / BP / EP / USPGMP CertifiedAurangabad, India
Umirolimus (Biolimus) API — Mediocon Inc
Umirolimus (Biolimus) — Pharmaceutical Grade API | Mediocon Inc, Aurangabad, Maharashtra, India

Product Overview

CAS No: 851536-75-9  |  MF: C₅₃H₈₃NO₁₄  |  MW: 966.23 g/mol

Umirolimus (Biolimus) is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.

Umirolimus (Biolimus A9) is a semi-synthetic macrolide immunosuppressant and mTOR inhibitor used in drug-eluting coronary stents to prevent restenosis. Its highly lipophilic nature allows rapid uptake by vascular smooth muscle cells, suppressing proliferation.

Key Features

  • High-purity pharmaceutical grade API
  • IP / BP / EP / USP compliant
  • Full CoA and MSDS documentation
  • GMP certified manufacturing facility

Applications

  • Drug-eluting coronary stent coating
  • Restenosis prevention
  • mTOR inhibition research
  • Immunosuppressant applications

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameUmirolimus (Biolimus)
Also Known AsBiolimus A9; TRM-986
CAS Number851536-75-9
Molecular FormulaC₅₃H₈₃NO₁₄
Molecular Weight966.23 g/mol
CategorymTOR Inhibitor / Drug-Eluting Stent API
AppearanceWhite to off-white amorphous powder
SolubilityPractically insoluble in water; highly soluble in organic solvents (ethanol, DMSO)
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch No.TPF/24033039
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Umirolimus (Biolimus) (CAS 851536-75-9) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Umirolimus (Biolimus) is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Umirolimus (Biolimus) API

What is the minimum order quantity for Umirolimus (Biolimus) API?
Mediocon Inc supplies Umirolimus (Biolimus) with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Umirolimus (Biolimus) does Mediocon supply?
We supply Umirolimus (Biolimus) conforming to IP / BP / EP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Umirolimus (Biolimus) API?
Every shipment of Umirolimus (Biolimus) comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Umirolimus (Biolimus) bulk orders?
Standard lead time for Umirolimus (Biolimus) is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?